Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer statistics, 2022.CA Cancer J Clin. 2022; 72: 7-33
- Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer.Ann Oncol. 2020; 31: 377-386
- National Comprehensive Cancer Network. Hepatobiliary Cancers.(Version 1.2022).(Available at:) (Accessed May 23, 2022)
- Gallbladder cancer: epidemiology and outcome.Clin Epidemiol. 2014; 6: 99-109
- Gallbladder Cancer Incidence and Mortality, United States 1999-2011.Cancer Epidemiol biomarkers Prev. 2015; 24: 1319-1326
- Incidental carcinoma of the gallbladder.Eur J Surg Oncol. 2002; 28: 4-10
- Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).J Surg Oncol. 2008; 98: 485-489
- Management of cancer gallbladder found as a surprise on a resected gallbladder specimen.J Surg Oncol. 2006; 93: 690-698
- Incidence of Cholangiocarcinoma in the USA from 2001 to 2015: A US Cancer Statistics Analysis of 50 States.Cureus. 2019; 11: e3962
- Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?.J Hepatol. 2004; 40: 472-477
- Adenocarcinoma of the Hepatic Duct at Its Bifurcation within the Porta Hepatis. An Unusual Tumor with Distinctive Clinical and Pathological Features.Am J Med. 1965; 38: 241-256
- Degree of biliary tract violation during treatment of gallbladder adenocarcinoma is independently associated with development of peritoneal carcinomatosis.J Surg Oncol. 2021; 124: 581-588
- Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw. 2021; 19: 541-565
- Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe.J Gastrointest Surg. 2003; 7: 850-856
- Management strategies in resection for hilar cholangiocarcinoma.Ann Surg. 1992; 215: 31-38
- Gallbladder cancer: expert consensus statement.HPB (Oxford). 2015; 17: 681-690
- The role of staging laparoscopy in primary gall bladder cancer--an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer.Ann Surg. 2013; 258: 318-323
- Incidental gallbladder cancer by the AFC-GBC-2009 Study Group.World J Surg. 2011; 35: 1887-1897
- Hepatic resection in 485 R0 pT2 and pT3 cases of advanced carcinoma of the gallbladder: results of a Japanese Society of Biliary Surgery survey--a multicenter study.J Hepatobiliary Pancreat Surg. 2009; 16: 204-215
- Analysis of the extent of resection for adenocarcinoma of the gallbladder.Ann Surg Oncol. 2009; 16: 806-816
- Is port site resection necessary in the surgical management of gallbladder cancer?.Ann Surg Oncol. 2012; 19: 409-417
- American Joint Committee on cancer (AJCC) staging Handbook: from the AJCC cancer staging Manual.8th edition. American Cancer Society, Cham, Switzerland2016
- Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment.Ann Surg. 2011; 254: 320-325
- Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.J Clin Oncol. 2011; 29: 3140-3145
- The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma.Ann Surg Oncol. 2015; 22: 4020-4028
- Response to the Comment on "Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis.Ann Surg. 2021; 274: e743
- Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis.Ann Surg. 2021; 274: e1187-e1195
- Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.Ann Surg. 2001; 234 ([discussion: 517–9]): 507-517
- Anatomical Basis of Routine Caudate Lobe Resections in Hilar Cholangiocarcinoma.J Gastrointest Surg. 2021; 25: 2114-2115
- Caudate lobe resection with major hepatectomy for central cholangiocarcinoma: is it of value?.Hepatogastroenterology. 2012; 59: 321-324
- A systematic review and meta-analysis of caudate lobectomy for treatment of hilar cholangiocarcinoma.Eur J Surg Oncol. 2020; 46: 747-753
- Molecular targeted therapies: Ready for "prime time" in biliary tract cancer.J Hepatol. 2020; 73: 170-185
- Biliary tract cancer.Lancet. 2021; 397: 428-444
- Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.JAMA Oncol. 2021; 7: 1669-1677
- Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.Lancet Oncol. 2020; 21: 671-684
- FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.Future Oncol. 2020; 16: 2385-2399
- Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.Cancer. 2003; 98: 1689-1700
- Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models.J Am Coll Surg. 2016; 223: 493-505 e2
- Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.N Engl J Med. 2010; 362: 1273-1281
- Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.J Clin Oncol. 2019; 37: 658-667
- Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.Lancet Oncol. 2019; 20: 663-673
- Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer.Br J Surg. 2018; 105: 192-202
- SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.J Clin Oncol. 2015; 33: 2617-2622
- Prospective Randomized Controlled Trial Comparing Adjuvant Chemotherapy vs. No Chemotherapy for Patients with Carcinoma of Gallbladder Undergoing Curative Resection.J Gastrointest Surg. 2022; 26: 398-407
- A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT).Jpn J Clin Oncol. 2018; 48: 392-395
- Adjuvant S-1 versus observation in curatively resected biliary tract cancer: A phase III trial (JCOG1202: ASCOT).J Clin Oncol. 2022; 40https://doi.org/10.1200/JCO.2022.40.4_suppl.382):382
- Deutsche Krebshilfe E.V. BGCRUAG-ITGDHC, (DHCG) CCG. Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After CurativeIntent Resection of Biliary Tract Cancer (ACTICCA-1).(Available at:) (Accessed April 20, 2022)
- Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer (OPT-IN EA2197).(Available at:) (Accessed April 20, 2022)
- NEO-GAP: A phase II single-arm prospective feasibility study of neoadjuvant gemcitabine/cisplatin/nab-paclitaxel for resectable high-risk intrahepatic cholangiocarcinoma.J Clin Oncol. 2022; : 4097
- Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.JAMA Oncol. 2020; 6: 60-67
Article info
Publication history
Published online: November 03, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
